Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -10.32 % |
3 Month Return | + 30.99 % |
1 Year Return | + 65.69 % |
Market Stats | |
Previous Close | ₹37.28 |
Open | ₹37.20 |
Volume | 3.34L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹836.04Cr |
P/E Ratio | 133.14 |
PEG Ratio | 91.82 |
Market Cap | ₹836.04 Cr |
P/B Ratio | 0.63 |
EPS | 0.22 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0.47 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹836.04 Cr | 38.25% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Nectar Lifescience Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Nectar Lifescience Ltd
Despite a decline in earnings over the last five years, Nectar Lifesciences has rewarded shareholders with an impressive total return of 85% in the past twelve months. The market's forward-looking nature is evident as the share price rose by 16% per year despite revenue shrinking by 13% annually.
Nectar Lifescience Q4 Net Sales Up 13.52% YoY - 20 May, 2024
Nectar Lifescience's consolidated net sales for March 2024 stood at Rs. 441.37 crore, up 13.52% YoY. However, the quarterly net profit decreased by 83.9% YoY to Rs. 0.59 crore. The EPS also decreased from Rs. 0.16 in March 2023 to Rs. 0.03 in March 2024. Nectar Lifescience shares closed at Rs. 33.75 on May 17, 2024 (NSE) and have given returns of 19.47% over the last 6 months and 98.53% over the last 12 months.
Nectar Lifescience Q4 2024 Net Sales Up 13.52% - 17 May, 2024
Nectar Lifescience's standalone net sales for March 2024 increased by 13.52% YoY, while quarterly net profit decreased by 88.83%. The company's EPS also decreased from Rs. 0.24 to Rs. 0.03 in the same period. However, Nectar Lifescience shares have given returns of 35.45% over the last six months and 98.26% over the last twelve months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 21.91% to 32.54% in Sep 2024 quarter
Profit Spike
Netprofit is up for the last 2 quarters, 0.59 Cr → 2.97 Cr (in ₹), with an average increase of 80.1% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 1.66% to 2.57% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 100.0%
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 18.1%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 44.35% of holdings in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 3 quarters, 452.65 Cr → 359.85 Cr (in ₹), with an average decrease of 10.5% per quarter
Price Dip
In the last 1 month, NECLIFE stock has moved down by -10.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.35% | 0.00 | |
Foreign Institutions | 2.57% | 55.34 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 32.54% | 48.50 | |
Others | 20.53% |
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Industry (58.10x)
October 18, 2024
Today (133.14x)
October 18, 2024
Highest (403.33x)
August 26, 2020
Nectar Lifescience Ltd’s net profit jumped 63.19% since last year same period to ₹2.97Cr in the Q1 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 403.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.14%.
Read More about DividendsBearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.
Nectar Lifescience Ltd (NECLIFE) share price today is ₹36.57
Nectar Lifescience Ltd is listed on NSE
Nectar Lifescience Ltd is listed on BSE
PE Ratio of Nectar Lifescience Ltd is 133.14
PE ratio = Nectar Lifescience Ltd Market price per share / Nectar Lifescience Ltd Earnings per share
Today’s traded volume of Nectar Lifescience Ltd(NECLIFE) is 3.34L.
Today’s market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹836.04Cr.
Nectar Lifescience Ltd(NECLIFE | Price |
---|---|
52 Week High | ₹56.5 |
52 Week Low | ₹21.5 |
Nectar Lifescience Ltd(NECLIFE) share price is ₹36.57. It is down -35.27% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd(NECLIFE) share price is ₹36.57. It is up 70.09% from its 52 Week Low price of ₹21.5
Nectar Lifescience Ltd(NECLIFE | Returns |
---|---|
1 Day Returns | -0.71% |
1 Month Returns | -10.32% |
3 Month Returns | 30.99% |
1 Year Returns | 65.69% |